Skip to main content
Log in

Extended depth-of-focus (EDOF) AcrySof® IQ Vivity® intraocular lens implant: a real-life experience

  • Cataract
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript



Extended depth-of-focus (EDOF) is a promising intraocular lens (IOL) technology for cataract surgery. The aim of the study was to report the real-life experience related to the implant of EDOF AcrySof® IQ Vivity® (Alcon Inc., USA) IOL.


The study was designed as a interventional, prospective, case series with 3 months of follow-up. Patients needing cataract surgery, without any other kind of ocular diseases, were recruited and implanted with AcrySof® IQ Vivity® IOL. We evaluated the refractive success of this IOL through complete ophthalmologic assessments and the administration of the Quality of Vision test. The main outcome measures were the refractive outcome; far, intermediate, and near vision; and Quality of Vision score.


We included 108 eyes (54 patients; age 62 ± 5 years). Intra-operative and post-operative complications were 0%. Thirty out of 100 eyes (28%) required toric IOL. Best-corrected visual acuity improved from 0.4 ± 0.3 LogMAR to 0.0 ± 0.0 LogMAR (p < 0.01). Refractive outcome was very good for far and intermediate visions, whereas a spherical addition of at least + 1.0D was required for near vision. The mean Quality of Vision score was of 15.5 ± 6.5. The most complained visual disturbances were haloes and glares, although resulting well-tolerated. Dynamic pupillometry findings well-correlated with the amount of complained post-operative visual discomforts.


AcrySof® IQ Vivity® IOL is a well-tolerated choice to correct far and intermediate vision. Spectacles are needed to optimize near vision. Our data strongly suggest dynamic pupillometry as a useful investigation to optimize post-operative refractive success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Kohnen T, Suryakumar R (2020) Extended depth-of-focus technology in intraocular lenses. J Cataract Refract Surg 46(2):298–304

    Article  Google Scholar 

  2. Hammond MD, Potvin R (2019) Visual outcomes, visual quality and patient satisfaction: comparing a blended bifocal approach to bilateral extended depth of focus intraocular lens implantation. Clin Ophthalmol 13:2325–2332

    Article  Google Scholar 

  3. Gundersen KG, Potvin R (2020) Comparing visual acuity, low contrast acuity and contrast sensitivity after trifocal toric and extended depth of focus toric intraocular lens implantation. Clin Ophthalmol 14:1071–1078

    Article  Google Scholar 

  4. Rocha KM (2017) Extended depth of focus IOLs: the next chapter in refractive technology? J Refract Surg 33(3):146–149

    Article  Google Scholar 

  5. Coassin M, Di Zazzo A, Antonini M, Gaudenzi D, Gallo Afflitto G, Kohnen T (2020) Extended depth-of-focus intraocular lenses: power calculation and outcomes. J Cataract Refract Surg 46(11):1554–1560

    Article  Google Scholar 

  6. AcrySoft IQ Vivity Extended Vision IOL product information. Accessed January 19, 2021.

  7. McAlinden C, Pesudovs K, Moore JE (2010) The development of an instrument to measure quality of vision: the Quality of Vision (QoV) questionnaire. Invest Ophthalmol Vis Sci 51(11):5537–5545

    Article  Google Scholar 

  8. Paik DW, Park JS, Yang CM, Lim DH, Chung TY (2020) Comparing the visual outcome, visual quality, and satisfaction among three types of multi-focal intraocular lenses. Sci Rep 10(1):14832

    Article  CAS  Google Scholar 

  9. Akman A, Asena L, Ozturk C, Gür GS (2019) Evaluation of quality of life after implantation of a new trifocal intraocular lens. J Cataract Refract Surg 45(2):130–134

    Article  Google Scholar 

  10. Rementería-Capelo LA, García-Pérez JL, Gros-Otero J, Carrillo V, Pérez-Lanzac J, Contreras I (2021) Real-world evaluation of visual results and patient satisfaction for extended range of focus intraocular lenses compared to trifocal lenses. Int Ophthalmol 41(1):163–172.

  11. Ozulken K, Kiziltoprak H, Yuksel E, Mumcuoğlu T (2021) A comparative evaluation of diffractive trifocal and new refractive/extended depth of focus intraocular lenses for refractive lens exchange. Curr Eye Res 46(6):811–817.

    Article  PubMed  Google Scholar 

  12. Braga-Mele R, Chang D, Dewey S, Foster G, Henderson BA, Hill W, Hoffman R, Little B, Mamalis N, Oetting T, Serafano D, Talley-Rostov A, Vasavada A, Yoo S, ASCRS Cataract Clinical Committee (2014) Multifocal intraocular lenses: relative indications and contraindications for implantation. J Cataract Refract Surg 40(2):313–322

    Article  Google Scholar 

  13. Tekin K, Sekeroglu MA, Kiziltoprak H, Doguizi S, Inanc M, Yilmazbas P (2018) Static and dynamic pupillometry data of healthy individuals. Clin Exp Optom 101(5):659–665

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Alessandro Arrigo.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

Francesco Bandello is a consultant for Alcon (Fort Worth, TX, USA), Alimera Sciences (Alpharetta, GA, USA), Allergan Inc. (Irvine, CA, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Schering Pharma (Berlin, Germany), Bausch And Lomb (Rochester, NY, USA), Genentech (San Francisco, CA, USA), Hoffmann-La-Roche (Basel, Switzerland), Novagali Pharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, USA). All other authors have no disclosures to declare.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arrigo, A., Gambaro, G., Fasce, F. et al. Extended depth-of-focus (EDOF) AcrySof® IQ Vivity® intraocular lens implant: a real-life experience. Graefes Arch Clin Exp Ophthalmol 259, 2717–2722 (2021).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: